Search
Close this search box.
    • Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Videos

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Life at Syngene: Spotlight on Computational & Data Sciences with Dr. Achintya Das

Watch this video of Dr. Achintya Das, Head of Computational & Data Sciences, speaking about Syngene’s proprietary modeling and AI solutions which help scientists make informed decisions across phases of drug discovery. He also talks about Syngene’s virtual liver platform HepTox, used for mechanistic assessment of exposure-dependent hepatotoxicity.

Syngene International Corporate video

Catch a glimpse of our ~ 2 Mn sq. ft. world-class R&D and manufacturing facility to understand how we put ‘Science to Work’ at Syngene. We are an innovation-led, contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

Annual Report 2023: Exceptional partnerships, dynamic growth

“Watch this video to catch a glimpse of the incredible milestones we have achieved over the past year. Explore how we are shaping the future of science and medicine with our collaborative partnerships based on the foundation of common interest, shared commitment, complementary skills, and desire to work together. To know more about the innovative solutions and transformative projects we delivered in FY2022-23, read our Annual Report

Science in 3 Minutes: Synthetic Peptides

In this video, Arunima Mukherjee from Syngene’s Discovery Chemistry team explains synthetic peptides, their applications, and how our team of scientists have enabled the generation of up to 50-mer linear peptides.

Science in 3 Minutes: Targeted Protein Degradation

In this video, Dr. Tony Kurissery shares some insights into Targeted Protein Degradation and how Syngene has enabled clients working on PROTACs.

Ask the Expert: Chemical Development

Watch this video to hear our Chemical Development expert, Dr. Raja Kaliappan, PhD., answer three big questions related to small molecule development and emerging trends in this space.

Ask the Expert: Biologics Development and Manufacturing

Hear our Biopharmaceutical Development expert, Dr Dhananjay Patankar, Ph.D., answer three big questions on Biologics Development and Manufacturing.

Ask the Expert: 3 big questions in Drug Product Development

Watch this video to hear our expert Purushottam Singnurkar on the key considerations in Formulation Development.

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy. and

To view or email, Please share your details view

To download, Please share your details